Epinecidin-1, a highly potent marine antimicrobial peptide with anticancer and immunomodulatory activities.
Anticancer
Antimicrobial peptide
Epinecidin-1
Epinephelus coioides
Immune response
Journal
BMC pharmacology & toxicology
ISSN: 2050-6511
Titre abrégé: BMC Pharmacol Toxicol
Pays: England
ID NLM: 101590449
Informations de publication
Date de publication:
28 05 2019
28 05 2019
Historique:
received:
03
01
2019
accepted:
30
04
2019
entrez:
30
5
2019
pubmed:
30
5
2019
medline:
31
1
2020
Statut:
epublish
Résumé
Antibiotic-resistant pathogens are an emerging threat in this century. Epinecidin-1 is a multi-functional Antimicrobial Peptide (AMP) produced by Orange-spotted grouper (Epinephelus coioides) has been shown to have extensive potentials as an alternative for current antibiotics. Due to the huge costs for the study and the production of a new drug, if an antimicrobial peptide has other beneficial functions in addition to antimicrobial activities, it would be preferred. In this study, properties and applications of Epinecidin-1 were investigated and addressed comprehensively. To achieve this, the Google Scholar search engine and three databases of PubMed, Scopus, and Web of Science were used. Epinecidin-1 is a cationic AMP with an alpha-helical structure. Seven functional usages of this peptide have been reported in the literature including antibacterial, antifungal, antiviral, antiprotozoal, anticancer, immunomodulatory, and wound healing properties. Moreover, this peptide has high potential to be used as an active ingredient in cleaning solutions as well as application in vaccine production. Due to significant antimicrobial activities tested on bacteria such as Staphylococcus aureus and Helicobacter pylori and also wound healing properties, Epi-1 has high potential to be considered as an important candidate for the production of new drugs and treatment of various infections including diabetic foot ulcer and peptic ulcer. Moreover, adjuvant-like properties of Epi-1 make it a suitable candidate for the studies related to an adjuvant. Other attractive properties such as anticancer effects have also been reported for this peptide which encourages further studies on this peptide.
Sections du résumé
BACKGROUND
Antibiotic-resistant pathogens are an emerging threat in this century. Epinecidin-1 is a multi-functional Antimicrobial Peptide (AMP) produced by Orange-spotted grouper (Epinephelus coioides) has been shown to have extensive potentials as an alternative for current antibiotics. Due to the huge costs for the study and the production of a new drug, if an antimicrobial peptide has other beneficial functions in addition to antimicrobial activities, it would be preferred.
METHODS
In this study, properties and applications of Epinecidin-1 were investigated and addressed comprehensively. To achieve this, the Google Scholar search engine and three databases of PubMed, Scopus, and Web of Science were used.
RESULTS
Epinecidin-1 is a cationic AMP with an alpha-helical structure. Seven functional usages of this peptide have been reported in the literature including antibacterial, antifungal, antiviral, antiprotozoal, anticancer, immunomodulatory, and wound healing properties. Moreover, this peptide has high potential to be used as an active ingredient in cleaning solutions as well as application in vaccine production.
CONCLUSION
Due to significant antimicrobial activities tested on bacteria such as Staphylococcus aureus and Helicobacter pylori and also wound healing properties, Epi-1 has high potential to be considered as an important candidate for the production of new drugs and treatment of various infections including diabetic foot ulcer and peptic ulcer. Moreover, adjuvant-like properties of Epi-1 make it a suitable candidate for the studies related to an adjuvant. Other attractive properties such as anticancer effects have also been reported for this peptide which encourages further studies on this peptide.
Identifiants
pubmed: 31138331
doi: 10.1186/s40360-019-0309-7
pii: 10.1186/s40360-019-0309-7
pmc: PMC6537373
doi:
Substances chimiques
Anti-Infective Agents
0
Antimicrobial Cationic Peptides
0
Antineoplastic Agents
0
Detergents
0
Fish Proteins
0
Immunologic Factors
0
Vaccines
0
epinecidin-1, Epinephelus coioides
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
33Références
Peptides. 2018 Aug;106:91-95
pubmed: 30012343
Fish Shellfish Immunol. 2009 Oct;27(4):571-6
pubmed: 19616630
Fish Shellfish Immunol. 2011 Dec;31(6):1019-25
pubmed: 21925271
Nat Methods. 2015 Jan;12(1):7-8
pubmed: 25549265
Avian Pathol. 2010 Oct;39(5):333-8
pubmed: 20954009
Mayo Clin Proc. 2018 Mar;93(3):307-320
pubmed: 29502561
Peptides. 2010 Aug;31(8):1449-58
pubmed: 20580756
Dis Aquat Organ. 2003 Jul 8;55(2):117-23
pubmed: 12911059
J Fish Biol. 2010 Aug;77(2):341-60
pubmed: 20646160
Biomaterials. 2015 Aug;61:41-51
pubmed: 25996410
Biomaterials. 2013 Dec;34(38):10319-27
pubmed: 24075409
Annu Rev Virol. 2018 Sep 29;5(1):33-51
pubmed: 29958082
Transbound Emerg Dis. 2017 Apr;64(2):316-332
pubmed: 25996568
Hum Vaccin Immunother. 2013 Apr;9(4):808-11
pubmed: 23563510
Mar Drugs. 2017 Nov 16;15(11):
pubmed: 29144391
Sci Rep. 2016 Jul 11;6:29707
pubmed: 27405275
DNA Cell Biol. 2007 Jun;26(6):403-13
pubmed: 17570764
Comp Biochem Physiol B Biochem Mol Biol. 2008 Aug;150(4):358-67
pubmed: 18514559
Biomaterials. 2011 May;32(14):3627-36
pubmed: 21316756
Virology. 2018 Jan 15;514:79-87
pubmed: 29153860
Fish Shellfish Immunol. 2010 Mar;28(3):434-9
pubmed: 20004246
Antimicrob Agents Chemother. 2014 Aug;58(8):4264-74
pubmed: 24820078
Peptides. 2019 Feb;112:139-148
pubmed: 30552913
Sci Rep. 2018 May 21;8(1):7951
pubmed: 29784969
Peptides. 2012 Jul;36(1):100-8
pubmed: 22521197
Oncotarget. 2017 Jul 11;8(28):46635-46651
pubmed: 28422728
Wound Repair Regen. 2014 Sep-Oct;22(5):613-21
pubmed: 25041740
Biochim Biophys Acta. 2009 Aug;1788(8):1680-6
pubmed: 19010301
Nucleic Acids Res. 2016 Jan 4;44(D1):D1087-93
pubmed: 26602694
Bioinformatics. 2017 Sep 1;33(17):2753-2755
pubmed: 28472272
Curr Med Chem. 2006;13(16):1859-76
pubmed: 16842198
Fish Shellfish Immunol. 2018 Oct;81:37-48
pubmed: 29981882
FEBS J. 2009 Nov;276(22):6497-508
pubmed: 19817855
Genes Dis. 2017 Jul 08;4(3):163-169
pubmed: 30258919
Fish Shellfish Immunol. 2017 Oct;69:153-163
pubmed: 28797637
Fish Shellfish Immunol. 2012 Jun;32(6):947-57
pubmed: 22554570
Biochim Biophys Acta. 2008 Feb;1778(2):357-75
pubmed: 18078805
Oncotarget. 2017 Jul 27;8(57):96615-96626
pubmed: 29228556
Peptides. 2010 May;31(5):806-15
pubmed: 20138098
Peptides. 2009 Jun;30(6):1058-68
pubmed: 19463737
J Biol Chem. 2002 Feb 15;277(7):5030-9
pubmed: 11739390
Peptides. 2009 Feb;30(2):283-90
pubmed: 19007829
Fish Shellfish Immunol. 2010 Jan;28(1):113-20
pubmed: 19819335
Oncotarget. 2017 Mar 28;8(13):21067-21080
pubmed: 28177877
Helicobacter. 2019 Feb;24(1):e12555
pubmed: 30440101
Eur J Biochem. 2003 Feb;270(4):675-86
pubmed: 12581207
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Fish Shellfish Immunol. 2015 Jan;42(1):1-15
pubmed: 25462461
Peptides. 2009 Dec;30(12):2365-73
pubmed: 19720101
PLoS One. 2015 Dec 08;10(12):e0143304
pubmed: 26646541
Acta Paediatr. 2006 Jan;95(1):3-5
pubmed: 16373288
Appl Environ Microbiol. 2015 Apr;81(8):2690-5
pubmed: 25662976
J Wound Care. 2018 Oct 2;27(10):646-658
pubmed: 30332358
Biol Direct. 2016 Oct 21;11(1):55
pubmed: 27769290
Front Chem. 2017 Feb 21;5:5
pubmed: 28271058
Saudi Pharm J. 2018 Mar;26(3):396-409
pubmed: 29556131